About the Institute : Organizational Structure

Organizational Structure

ISCI administration includes three levels of governance. All governing boards advise Dr. Joshua M. Hare, Founding Director, Interdisciplinary Stem Cell Institute.

ISCI Governing Board of Directors (GAB)

The ISCI Governing Board of Directors (GAB) oversees and provides input on ISCI governance and operations, ensuring a clear vision and strategic direction, goals and policies are set. In addition, the GAB identifies collaborative leadership and effective partnerships, assists in fundraising and government and community relations, identifies novel therapies that have commercial potential for possible spin-off companies and reviews the performance of ISCI and its Director. Members of the GAB include:

  • Eduardo C. Alfonso, M.D., Professor of Ophthalmology, Kathleen and Stanley J. Glaser Chair in Ophthalmology, Chairman, Department of Ophthalmology, Director, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.
  • W. Dalton Dietrich, III, Ph.D., Scientific Director, The Miami Project to Cure Paralysis, Kinetic Concepts Distinguished Chair in Neurosurgery, Senior Associate Dean for Discovery Science, Professor of Neurological Surgery, Neurology adn Cell Biology and Anatomy
  • Pascal Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean, University of Miami Miller School of Medicine, Chief Executive Officer, University of Miami Health System.
  • Joshua M. Hare, M.D., F.A.C.C., F.A.H.A., Louis Lemberg Professor of Medicine and Founding Director, Interdisciplinary Stem Cell Institute.
  • Norma S. Kenyon, Ph.D., Martin Kleiman Professor of Surgery, Microbiology & Immunology adn Biomedical Engineering, Executive Director, Wallace H. Coulter Center for Translational Research, Senior Associate Dean for Translational Science
  • Jeffrey D. Molkentin, Ph.D., Professor, Howard Hughes Medical Institute, Molecular Cardiovascular Biology, Cincinnati Children’s Hospital Medical Center.
  • Ralph L. Sacco, M.D., M.S., F.A.H.A., F.A.A.N., Professor of Neurology, Epidemiology and Human Genetics, Olemberg Family Chair in Neurological Disorders, University of Miami Miller School of Medicine, Chief of Neurology Services, Jackson Memorial Hospital.
  • H. Allan Shore, Esq., Partner, Wealth Transfer Co-Chair, Bilzin, Sumberg, Baena, Price, & Axelrod, LLP.
  • Bernard Siegel, Esq., Founder and Executive Director, Genetics Policy Institute.

ISCI Scientific Advisory Committee (SAC)

The ISCI Scientific Advisory Committee (SAC) provides recommendations on all scientific, technical and policy issues that have bearing on the full and effective utilization of ISCI state-of-the-art research institute and on future developments required to maintain the scientific and technical productivity at the highest possible level. The SAC reviews existing and proposed new programs, considering the mix of scientific research platforms and their ancillary laboratories and equipment. Members of the SAC include:

  • Piero Anversa, M.D., Director Center for Regenerative Medicine, Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School.
  • Curt Civin M.D., Associate Dean for Research, Director, Center for Stem Cell Biology & Regenerative Medicine, Professor of Pediatrics, University of Maryland, School of Medicine.
  • Joshua M. Hare, M.D., F.A.C.C., F.A.H.A., Louis Lemberg Professor of Medicine and Founding Director, Interdisciplinary Stem Cell Institute.
  • Armand Keating, M.D., Professor of Medicine, Director, Center for Stem Cell Biology & Regenerative Medicine, University of Toronto in Toronto, Canada.
  • Jeffery D. Molkentin, Ph.D., Professor, Howard Hughes Medical Institute, Cincinnati Children’s Hospital Medical Center, Molecular Cardiovascular Biology.
  • Joseph Wu, M.D., Ph.D., Assistant Professor in the Department of Medicine (Cardiology) and Department of Radiology at the Stanford School of Medicine.
  • Benjamin Reubinoff M.D. Ph.D., Director, The Hadassah Human Embryonic Stem Cell Research Center, Sidney Swartz Chair in Human Embryonic Stem Cell Research, The Department of Gynecology and The Goldyne Savad Institute of Gene Therapy, Hadassah University Medical Center, Jerusalem, Israel.

ISCI Platform Advisory Committee (PAC)

The ISCI Platform Advisory Committee (PAC) ensures that the vision of the SAC and GAB is executed across platform activities. Comprised of faculty members, the PAC identifies collaborations and effective partnerships as important means for quality enhancement, adding value and continuous improvement to ISCI Platforms. In addition, the PAC identifies novel therapies that have commercial potential for possible spin-off companies and makes recommendations regarding research on emerging therapies using stem cells. PAC members include:

  • Herman Cheung, Ph.D., James L. Knight Professor of Biomedical Engineering, Senior VA Research Career Scientist, Professor of Medicine and Orthopedic Surgery.
  • Robin N. Fiore, Ph.D., Associate Professor (pending), Ethics Program.
  • Kenneth W. Goodman, Ph.D., F.A.C.M.I., Bioethics Program Director and Co-Director, Ethics Programs.
  • James M. Grichnik, M.D., Ph.D., Professor, Department of Dermatology and Cutaneous Surgery, Director, Melanoma Program.
  • Joshua M. Hare, M.D., F.A.C.C., F.A.H.A., Louis Lemberg Professor of Medicine and Founding Director, Interdisciplinary Stem Cell Institute.
  • Michael S. Kapiloff, M.D., Ph.D., F.A.H.A., Associate Professor, Division of Cardiology, Departments of Pediatrics and Medicine, Director, Cardiac Signal Transduction and Cellular Biology Laboratory.
  • Krishna Komanduri, M.D., Director, Sylvester Stem Cell Transplantation Program, Associate Director, Translational Research, Miami Transplant Institute, Jackson Memorial Hospital.
  • Ian K. McNiece, Ph.D., Professor of Medicine, Department of Medicine, Director, Experimental and Clinical Cell Based Therapies Program.
  • Dileep R. Yavagal, M.D., Assistant Professor of Clinical Neurology and Neurosurgery, Director of Interventional Neurology, Co-Director of Endovascular Neurosurgery.

About the Institute